郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价Synthesis and pharmacological evaluation of dimeric follicle-stimulating hormone receptor antagonists.

期刊:ChemMedChem发表年份:2009作者:Kimberly M Bonger; Sascha Hoogendoorn; Chris J van Koppen; Cornelis M Timmers; Herman S Overkleeft; Gijsbert A van der Marel

药效评价FLIPR assays of intracellular calcium in GPCR drug discovery.

期刊:Methods in molecular biology (Clifton, N.J.)发表年份:2009作者:Kasper B Hansen; Hans Bräuner-Osborne

药效评价Discovery of a new class of non-imidazole oxazoline-based histamine H(3) receptor (H(3)R) inverse agonists.

期刊:ChemMedChem发表年份:2009作者:Sylvain Célanire; Maikel Wijtmans; Bernard Christophe; Philippe Collart; Iwan de Esch; Donald Dassesse; Christel Delaunoy; Frédéric Denonne; Véronique Durieu; Edith Gelens; Michel Gillard; Bénédicte Lallemand; Yves Lamberty; Florence Lebon; Jean-Mari

药效评价Synthesis and evaluation of a full-agonist orvinol for PET-imaging of opioid receptors: [11C]PEO.

期刊:Journal of medicinal chemistry发表年份:2009作者:János Marton; Bent W Schoultz; Trine Hjørnevik; Alexander Drzezga; Behrooz H Yousefi; Hans-Jürgen Wester; Frode Willoch; Gjermund Henriksen